MARKET

TGRP

TGRP

Tron Group
OTCID
0.028
-0.009
-25.14%
Closed 09:30 12/04 EST
OPEN
0.028
PREV CLOSE
0.037
HIGH
0.028
LOW
0.028
VOLUME
100
TURNOVER
3
52 WEEK HIGH
0.090
52 WEEK LOW
0.020
MARKET CAP
5.10M
P/E (TTM)
-8.1471
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TGRP last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at TGRP last week (1117-1121)?
Weekly Report · 11/24 10:13
Weekly Report: what happened at TGRP last week (1110-1114)?
Weekly Report · 11/17 10:13
Weekly Report: what happened at TGRP last week (1103-1107)?
Weekly Report · 11/10 10:11
Weekly Report: what happened at TGRP last week (1027-1031)?
Weekly Report · 11/03 10:11
Weekly Report: what happened at TGRP last week (1020-1024)?
Weekly Report · 10/27 10:14
Weekly Report: what happened at TGRP last week (1013-1017)?
Weekly Report · 10/20 10:11
Weekly Report: what happened at TGRP last week (1006-1010)?
Weekly Report · 10/13 10:13
More
About TGRP
Tron Pharmaceuticals, Inc. formerly Nanopharmaceutics, Inc., is a clinical-stage specialty pharmaceutical company. The Company is developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. It is developing a clinical pipeline of oral, topical and injectable small molecule drug candidates to treat human cancer, central nervous system (CNS) disorders and infectious diseases. Its pipeline includes 10 clinical-stage proprietary and partnered programs including Triapine, Ammonium Tetrathiomolybdate and Aza-TdC, targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3, targeting CNS; and Ramoplanin and NanoDOX, targeting infectious disease. Leveraging its expertise in nanoparticle and fine-particle formulations, the Company is focused on formulation development aimed at improving drug absorption and stability. Its Triapine is a synthetic heterocyclic carboxaldehyde thiosemicarbazone with potential antineoplastic activity.

Webull offers Tron Pharmaceuticals Inc stock information, including OTCID: TGRP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TGRP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TGRP stock methods without spending real money on the virtual paper trading platform.